Skip to main content

Advertisement

Table 5 Glaucoma medications usage in both groups

From: Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma

  Pre-surgery 2 weeks 1 month 3 months 6 months 12 months
Injection Group 2.5 ± 0.5 0.2 ± 0.4 0.6 ± 0.6 0.7 ± 0.6 1.0 ± 0.7 1.1 ± 0.8
Control Group 2.6 ± 0.5 0.2 ± 0.4 0.7 ± 0.7 0.7 ± 0.7 1.1 ± 0.8 1.3 ± 0.9
P 0.66 0.94 0.59 0.93 0.71 0.47
  1. Note: The differences in the number of glaucoma medications used at various time points throughout follow-up were compared between the two groups using the t test